An Educational Opportunity for Clinicians Specializing in the diagnosis of
Clostridium difficile Infections

Overview of C. diff Formative Assessment CME Activity

Loading the player ...

Put your knowledge to the test and see how you stack up relative to your fellow clinicians! Challenge yourself with this self-paced interactive assessment designed to sharpen your knowledge and competency in the diagnosis and management of Clostridium difficile infections.

Put your knowledge to the test and see how you stack up relative to your fellow clinicians.

Complete this assessment to obtain your personalized learning profile and earn CME credit

Challenge yourself with this self-paced activity that is chaired by thought leaders

Learning Objectives

Upon completion of this activity participants will be able to:

  • Outline diagnostic criteria and levels of disease severity for C. diff infection
  • Discuss available and emerging pharmacotherapies for C. diff infection
  • Evaluate therapeutic interventions for the management of severe-complicated and recurrent C. diff infection


The following financial disclosures have been provided:

Stuart H. Cohen, MD, FACP, FIDSA(Chair)
Consultant: Cubist Pharmaceuticals, Merck and Pfizer
Research Support: Cubist Pharmaceuticals and ViroPharma

Dale N. Gerding, MD (Faculty) 
Advisory Board: Actelion, Merck and Rebiotix
Consultant: Sanofi-Pasteur and ViroPharma
Steering Committee: Sanofi-Pasteur

Ciarán P. Kelly, MD (Faculty)
Advisory Board: Cubist Pharmaceuticals

Discussion of Off-Label, Investigational, or Experimental Drug Use: The faculty may discuss the use of metronidazole for the treatment of C. diff infections

Staff and Reviewer Disclosures

ACHL staff members and others involved with the planning, development, and review of the content for this activity have no relevant affiliations or financial relationships to disclose.


This activity is supported by an educational grant from Cubist Pharmaceuticals


Sponsored by the Academy for Continued Healthcare Learning